Workflow
虚拟治疗和健康服务
icon
Search documents
Teladoc(TDOC) - 2025 Q3 - Earnings Call Presentation
2025-10-29 21:00
Financial Performance - Q3 2025 - Revenue for 3Q-25 was $626 million, a decrease of 2% year-over-year[4] - Net loss per share for 3Q-25 was $(0.28)[4] - Adjusted EBITDA for 3Q-25 was $69.9 million, a decrease of 16% year-over-year[4] Financial Outlook - FY25 - The company projects FY-25 revenue to be in the range of $2,510 million to $2,539 million[5] - The company projects FY-25 net loss per share to be in the range of $(1.25) to $(1.10)[5] - The company projects FY-25 Adjusted EBITDA to be in the range of $270 million to $287 million[5] Financial Outlook - Q4 2025 - The company projects 4Q-25 revenue to be in the range of $622 million to $652 million[5] - The company projects 4Q-25 net loss per share to be in the range of $(0.25) to $(0.10)[5] - The company projects 4Q-25 Adjusted EBITDA to be in the range of $73 million to $90 million[5] Balance Sheet and Cash Flow - Cash and cash equivalents as of September 30, 2025, were $726 million[36] - Convertible senior notes as of September 30, 2025, were $994 million[36] - Operating cash flow for 3Q-25 was $99 million[36] - Free cash flow for 3Q-25 was $68 million[36]